Summit Partners Public Asset Management, LLC Bio N Tech Se Transaction History
Summit Partners Public Asset Management, LLC
- $2.79 Billion
- Q3 2024
A detailed history of Summit Partners Public Asset Management, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Summit Partners Public Asset Management, LLC holds 90,000 shares of BNTX stock, worth $10.1 Million. This represents 0.43% of its overall portfolio holdings.
Number of Shares
90,000Holding current value
$10.1 Million% of portfolio
0.43%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding BNTX
# of Institutions
364Shares Held
38.3MCall Options Held
2.52MPut Options Held
2.18M-
Baillie Gifford & CO8.22MShares$920 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$493 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$481 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$212 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$202 Million0.88% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $27.2B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...